https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-01 / Cell Oncol (Dordr) 2015 Aug;38(4):279-88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-01 / Cell Oncol (Dordr) 2015 Aug;38(4):279-882015-05-01 00:00:002015-05-01 00:00:00Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-03-01 / Anticancer Res. 2015 Mar;35(3):1575-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-03-01 / Anticancer Res. 2015 Mar;35(3):1575-822015-03-01 00:00:002019-02-15 08:48:13Matched-pair analysis of dendritic cell versus targeted-therapy in patients with metastatic renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-23 / J Transl Med 2014 Sep;12:262
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-23 / J Transl Med 2014 Sep;12:2622014-09-23 00:00:002019-02-15 08:49:57Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-08-05 / Int. J. Cancer 2015 Feb;136(4):E74-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-08-05 / Int. J. Cancer 2015 Feb;136(4):E74-842014-08-05 00:00:002019-02-15 08:46:15Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 490)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 490)2014-07-31 11:52:432021-08-09 07:54:15A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3085)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3085)2014-06-01 00:00:002021-08-09 07:54:01Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diganosed metastatic renal cell carcinoma (mRCC).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)2013-06-03 00:00:002021-08-09 07:55:21Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines ± CYT107 (rhIL-7).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-03-18 / J. Interferon Cytokine Res. 2013 Jul;33(7):346-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-03-18 / J. Interferon Cytokine Res. 2013 Jul;33(7):346-542013-03-18 00:00:002013-03-18 00:00:00The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-03-04 / Hum Vaccin Immunother 2013 Jun;9(6):1217-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-03-04 / Hum Vaccin Immunother 2013 Jun;9(6):1217-272013-03-04 00:00:002019-02-15 08:48:05Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-06-01 / J Clin Oncol 30, 2012 (suppl; abstr e15053)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-06-01 / J Clin Oncol 30, 2012 (suppl; abstr e15053)2012-06-01 00:00:002021-08-09 07:54:41Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.